AITech.euabout 2 hours ago
Sightera raises €3M for AI drug platform
2 min read
Sightera Biosciences, a Belgian techbio spin-off from the University of Antwerp and UZA, raised €3 million in pre-seed funding led by Entourage, Anacura, and QBIC. The company uses generative AI and proprietary patient-derived data to design small-molecule therapies for oncology and fibrosis, aiming to improve clinical translation.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
